Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Ho

Showing results (331-340 of 1,575) with videos related to

Pageof 158
Sort By:
British Journal of Haematology|August 6, 2003
Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemiaManfred Hensel, Martin Kornacker, Sophie Yammeni, et al.
Journal of Interferon Research|May 1, 1992
Deficiency in interferon production of peripheral blood leukocytes from patients with non-Hodgkin lymphomaA D Ho, T Moritz, K Rensch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Combination therapy of Thalidomide and Peginterferon in patients with progressive multiple myelomaB Kasper, T Moehler, K Neben, et al.
European Journal of Haematology|February 24, 2011
Charcot-Leyden crystals and bone marrow necrosis in acute myeloid leukemiaAleksandar Radujkovic, Frauke Bellos, Mindaugas Andrulis, et al.
Journal of the American Chemical Society|January 31, 2012
Carbon-nitrogen bond formation in the reaction between tetrakis(dimethylamido)molybdenum(IV) and 2,6-dimethylphenyl isocyanide. Preparation and characterization of the first homoleptic metallaamidine complex: Mo(.eta.2-Me2NC:NC6H3Me3-2,6)4M H Chisholm, C E Hammond, D Ho, et al.
The Journal of Biological Chemistry|December 29, 1998
IQGAP1 integrates Ca2+/calmodulin and Cdc42 signalingY D Ho, J L Joyal, Z Li, et al.
The New England Journal of Medicine|April 4, 1991
Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infectionE S Daar, T Moudgil, R D Meyer, et al.
Journal of Leukocyte Biology|February 28, 2002
Functional characterization of podia formation in normal and malignant hematopoietic cellsS Fruehauf, K Srbic, R Seggewiss, et al.
Journal of Clinical Pathology|July 1, 1995
The value of Toxoplasma specific IgA in diagnosisD Ashburn, A W Joss, D Ho-Yen, et al.
The New England Journal of Medicine|January 26, 1995
Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infectionY Cao, L Qin, L Zhang, et al.
Pageof 158

Showing results (331-340 of 1,575) with videos related to

Sort By:
Pageof 158
British Journal of Haematology|August 6, 2003
Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemiaManfred Hensel, Martin Kornacker, Sophie Yammeni, et al.
Journal of Interferon Research|May 1, 1992
Deficiency in interferon production of peripheral blood leukocytes from patients with non-Hodgkin lymphomaA D Ho, T Moritz, K Rensch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 18, 2003
Combination therapy of Thalidomide and Peginterferon in patients with progressive multiple myelomaB Kasper, T Moehler, K Neben, et al.
European Journal of Haematology|February 24, 2011
Charcot-Leyden crystals and bone marrow necrosis in acute myeloid leukemiaAleksandar Radujkovic, Frauke Bellos, Mindaugas Andrulis, et al.
Journal of the American Chemical Society|January 31, 2012
Carbon-nitrogen bond formation in the reaction between tetrakis(dimethylamido)molybdenum(IV) and 2,6-dimethylphenyl isocyanide. Preparation and characterization of the first homoleptic metallaamidine complex: Mo(.eta.2-Me2NC:NC6H3Me3-2,6)4M H Chisholm, C E Hammond, D Ho, et al.
The Journal of Biological Chemistry|December 29, 1998
IQGAP1 integrates Ca2+/calmodulin and Cdc42 signalingY D Ho, J L Joyal, Z Li, et al.
The New England Journal of Medicine|April 4, 1991
Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infectionE S Daar, T Moudgil, R D Meyer, et al.
Journal of Leukocyte Biology|February 28, 2002
Functional characterization of podia formation in normal and malignant hematopoietic cellsS Fruehauf, K Srbic, R Seggewiss, et al.
Journal of Clinical Pathology|July 1, 1995
The value of Toxoplasma specific IgA in diagnosisD Ashburn, A W Joss, D Ho-Yen, et al.
The New England Journal of Medicine|January 26, 1995
Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infectionY Cao, L Qin, L Zhang, et al.
Pageof 158